Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (261-270 of 311) with videos related to

Pageof 32
Sort By:
The Lancet. Rheumatology|August 1, 2025
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trialJacques Morel, Emmanuelle Dernis, Christian Roux, et al.
Rheumatology (Oxford, England)|May 10, 2015
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacyDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Drugs & Aging|February 23, 2021
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's SyndromeSoledad Retamozo, Chiara Baldini, Hendrika Bootsma, et al.
Haematologica|May 30, 2020
Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 casesPhilippe Mertz, Emilie Chalayer, Zahir Amoura, et al.
Annals of the Rheumatic Diseases|January 28, 2025
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trialAdeline Ruyssen-Witrand, Clara Brusq, Maëva Masson, et al.
Medicine|April 11, 2015
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter studyHélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, et al.
Annals of the Rheumatic Diseases|October 29, 2024
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trialAdeline Ruyssen-Witrand, Clara Brusq, Maëva Masson, et al.
RMD Open|January 6, 2025
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort studyFélicien Triboulet, Pierre-Antoine Juge, Marie-Elise Truchetet, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Rheumatology (Oxford, England)|August 19, 2020
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registriesDelphine S Courvoisier, Katarina Chatzidionysiou, Denis Mongin, et al.
Pageof 32

Showing results (261-270 of 311) with videos related to

Sort By:
Pageof 32
The Lancet. Rheumatology|August 1, 2025
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trialJacques Morel, Emmanuelle Dernis, Christian Roux, et al.
Rheumatology (Oxford, England)|May 10, 2015
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacyDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Drugs & Aging|February 23, 2021
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's SyndromeSoledad Retamozo, Chiara Baldini, Hendrika Bootsma, et al.
Haematologica|May 30, 2020
Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 casesPhilippe Mertz, Emilie Chalayer, Zahir Amoura, et al.
Annals of the Rheumatic Diseases|January 28, 2025
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trialAdeline Ruyssen-Witrand, Clara Brusq, Maëva Masson, et al.
Medicine|April 11, 2015
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter studyHélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, et al.
Annals of the Rheumatic Diseases|October 29, 2024
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trialAdeline Ruyssen-Witrand, Clara Brusq, Maëva Masson, et al.
RMD Open|January 6, 2025
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort studyFélicien Triboulet, Pierre-Antoine Juge, Marie-Elise Truchetet, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Rheumatology (Oxford, England)|August 19, 2020
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registriesDelphine S Courvoisier, Katarina Chatzidionysiou, Denis Mongin, et al.
Pageof 32